speb/financial-data huggingface dataset:
KLIN.SW balance_sheet (annual, 2024-03-31) — Retained Earnings: 70830000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Sale Of Intangibles: 0.00
KLIN.SW cash_flow (annual, 2024-03-31) — Sale Of Investment: 334000.00
KLIN.SW cash_flow (annual, 2024-03-31) — Sale Of PPE: 637000.00
KLIN.SW income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 7100000.00
KLIN.SW income_statement (annual, 2024-03-31) — Selling General And Administration: 10300000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Share Issued: 8840000.00
KLIN.SW income_statement (annual, 2024-03-31) — Special Income Charges: 9000000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Stockholders Equity: 140752000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Tangible Book Value: 140148000.00
KLIN.SW income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 2134800.00
KLIN.SW income_statement (annual, 2024-03-31) — Tax Provision: 5350000.00
KLIN.SW income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.24
KLIN.SW balance_sheet (annual, 2024-03-31) — Taxes Receivable: 2400000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Total Assets: 296124000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Total Capitalization: 140752000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 140752000.00
KLIN.SW income_statement (annual, 2024-03-31) — Total Expenses: 288422000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 155372000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 75728000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 27189000.00
KLIN.SW income_statement (annual, 2024-03-31) — Total Operating Income As Reported: 25067000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Total Tax Payable: 4500000.00
KLIN.SW income_statement (annual, 2024-03-31) — Total Unusual Items: 9000000.00
KLIN.SW income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 9000000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 0.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Work In Process: 65236000.00
KLIN.SW balance_sheet (annual, 2024-03-31) — Working Capital: 92213000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 16055000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 51206000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 1092000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Capital Stock: 28639000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 14091000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 14091000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Common Stock: 28639000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 130970000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Current Assets: 212213000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 132981000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Current Provisions: 5655000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 1338000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Hedging Assets Current: 11000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Inventory: 135720000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Invested Capital: 130970000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 1092000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Investmentsin Joint Venturesat Cost: 2647000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 2647000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 12567000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Net PPE: 60432000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 129632000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 12934000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 2018000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 8840000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 48914000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Other Receivables: 11185000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Payables: 16055000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Retained Earnings: 63385000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Share Issued: 8840000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 130970000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 129632000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Total Assets: 290656000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 130970000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 130970000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 159686000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 78443000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 26705000.00
KLIN.SW balance_sheet (quarterly, 2024-09-30) — Working Capital: 79232000.00
KLIN.SW income_statement (annual, 2025-03-31) — +Operating Expense: 165684000.00
KLIN.SW income_statement (annual, 2025-03-31) — +Total Revenue: 309069000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Accounts Payable: 17441000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 17441000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Accounts Receivable: 70183000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 70183000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -72187000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -72187000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -165000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -165000.00
KLIN.SW income_statement (annual, 2025-03-31) — Amortization: 362000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 363000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 131000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 131000.00
KLIN.SW income_statement (annual, 2025-03-31) — Basic Average Shares: 8840000.00
KLIN.SW income_statement (annual, 2025-03-31) — Basic EPS: 1.13
KLIN.SW cash_flow (annual, 2025-03-31) — Beginning Cash Position: 16506000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Capital Expenditure: -9024000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Capital Stock: 28639000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Capital Stock: 28639000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 16008000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 16008000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 16008000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 16008000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -4674000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Change In Inventory: 10913000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -13487000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Change In Payable: -1415000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Change In Receivables: 10617000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Change In Working Capital: 4385000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Changes In Cash: -350000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Common Stock: 28639000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Common Stock: 28639000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Common Stock Equity: 143373000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 143373000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Construction In Progress: 2692000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 2692000.00
KLIN.SW income_statement (annual, 2025-03-31) — Cost Of Revenue: 127976000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Current Assets: 200905000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Current Assets: 200905000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Current Liabilities: 111743000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 111743000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Current Provisions: 4336000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Current Provisions: 4336000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Defined Pension Benefit: 1000000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Defined Pension Benefit: 1000000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Depreciation: 5262000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 5625000.00
KLIN.SW income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 5625000.00
KLIN.SW income_statement (annual, 2025-03-31) — Depreciation Income Statement: 5263000.00
KLIN.SW income_statement (annual, 2025-03-31) — Diluted Average Shares: 8840000.00
KLIN.SW income_statement (annual, 2025-03-31) — Diluted EPS: 1.13
KLIN.SW income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 9985000.00
KLIN.SW income_statement (annual, 2025-03-31) — EBIT: 16846000.00
KLIN.SW income_statement (annual, 2025-03-31) — EBITDA: 22471000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: -148000.00
KLIN.SW cash_flow (annual, 2025-03-31) — End Cash Position: 16008000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Financing Cash Flow: -6844000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Finished Goods: 10498000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Finished Goods: 10498000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Free Cash Flow: 9946000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 197000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 1408000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1408000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 70348000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 70348000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Gross PPE: 133795000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Gross PPE: 133795000.00
KLIN.SW income_statement (annual, 2025-03-31) — Gross Profit: 181093000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Hedging Assets Current: 16000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 16000.00
KLIN.SW income_statement (annual, 2025-03-31) — Interest Expense: 1823000.00
KLIN.SW income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 1823000.00
KLIN.SW income_statement (annual, 2025-03-31) — Interest Income: 168000.00
KLIN.SW income_statement (annual, 2025-03-31) — Interest Income Non Operating: 168000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Inventories Adjustments Allowances: -13286000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Inventories Adjustments Allowances: -13286000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Inventory: 104385000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Inventory: 104385000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Invested Capital: 143373000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Invested Capital: 143373000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Investing Cash Flow: -12476000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 131000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 131000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Investmentsin Joint Venturesat Cost: 3131000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Investmentsin Joint Venturesat Cost: 3131000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 3131000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 3131000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Long Term Provisions: 11948000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 11948000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 44463000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 44463000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: -3526000.00
KLIN.SW income_statement (annual, 2025-03-31) — Net Income: 9985000.00
KLIN.SW income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 9985000.00
KLIN.SW income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 9985000.00
KLIN.SW income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 9985000.00
KLIN.SW income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 9985000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 9985000.00
KLIN.SW income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 9985000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Net Intangibles Purchase And Sale: -487000.00
KLIN.SW income_statement (annual, 2025-03-31) — Net Interest Income: -1655000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 17000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -2170000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -1866000.00
KLIN.SW income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -1655000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Net PPE: 61608000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Net PPE: 61608000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -8480000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: -304000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 141965000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 141965000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 11906000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 11906000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 1492000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 1492000.00
KLIN.SW income_statement (annual, 2025-03-31) — Normalized EBITDA: 22471000.00
KLIN.SW income_statement (annual, 2025-03-31) — Normalized Income: 9985000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Operating Cash Flow: 18970000.00
KLIN.SW income_statement (annual, 2025-03-31) — Operating Income: 15409000.00
KLIN.SW income_statement (annual, 2025-03-31) — Operating Revenue: 309069000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 8840000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 8840000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 5841000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 5841000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 1408000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1408000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Other Inventories: 50206000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Other Inventories: 50206000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Other Non Cash Items: -415000.00
KLIN.SW income_statement (annual, 2025-03-31) — Other Operating Expenses: 43510000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Other Properties: 26432000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Other Properties: 26432000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Other Receivables: 6613000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Other Receivables: 6613000.00
KLIN.SW income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Payables: 22141000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Payables: 22141000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Prepaid Assets: 1000000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 1000000.00
KLIN.SW income_statement (annual, 2025-03-31) — Pretax Income: 15023000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Properties: 60208000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Properties: 60208000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Purchase Of Business: -3526000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Purchase Of Intangibles: -487000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Purchase Of Investment: 0.00
KLIN.SW cash_flow (annual, 2025-03-31) — Purchase Of PPE: -8537000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Raw Materials: 658000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Raw Materials: 658000.00
KLIN.SW income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 127976000.00
KLIN.SW income_statement (annual, 2025-03-31) — Reconciled Depreciation: 5625000.00
KLIN.SW income_statement (annual, 2025-03-31) — Rent And Landing Fees: 3200000.00
KLIN.SW income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 3200000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Retained Earnings: 75788000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 75788000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Sale Of Investment: 17000.00
KLIN.SW cash_flow (annual, 2025-03-31) — Sale Of PPE: 57000.00
KLIN.SW income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 8000000.00
KLIN.SW income_statement (annual, 2025-03-31) — Selling General And Administration: 8000000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Share Issued: 8840000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Share Issued: 8840000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Stockholders Equity: 143373000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 143373000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Tangible Book Value: 141965000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 141965000.00
KLIN.SW income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
KLIN.SW income_statement (annual, 2025-03-31) — Tax Provision: 5038000.00
KLIN.SW income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.34
KLIN.SW balance_sheet (annual, 2025-03-31) — Taxes Receivable: 2700000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 2700000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Total Assets: 280089000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Total Assets: 280089000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Total Capitalization: 143373000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 143373000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 143373000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 143373000.00
KLIN.SW income_statement (annual, 2025-03-31) — Total Expenses: 293660000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 136716000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 136716000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 79184000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 79184000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 24973000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 24973000.00
KLIN.SW income_statement (annual, 2025-03-31) — Total Operating Income As Reported: 16216000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Total Tax Payable: 4700000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 4700000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Work In Process: 56309000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Work In Process: 56309000.00
KLIN.SW balance_sheet (annual, 2025-03-31) — Working Capital: 89162000.00
KLIN.SW balance_sheet (quarterly, 2025-03-31) — Working Capital: 89162000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 17728000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 41257000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 1387000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Capital Stock: 28639000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 20562000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 20562000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Common Stock: 28639000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 119894000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Current Assets: 202505000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 134748000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Current Provisions: 3720000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 1453000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Hedging Assets Current: 0.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Inventory: 128481000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Invested Capital: 119894000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 1387000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Investmentsin Joint Venturesat Cost: 2265000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 2265000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 12125000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Net PPE: 59938000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 118441000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 11307000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 1961000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 8840000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 45051000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Other Receivables: 12205000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Payables: 17728000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 54674000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Share Issued: 8840000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 119894000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 118441000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Total Assets: 278882000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 119894000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 119894000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 158988000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 76377000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 24240000.00
KLIN.SW balance_sheet (quarterly, 2025-09-30) — Working Capital: 67757000.00
KLIN.SW income_statement (annual, 2026-03-31) — +Operating Expense: 161203000.00
KLIN.SW income_statement (annual, 2026-03-31) — +Total Revenue: 285390000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Accounts Payable: 21360000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 21360000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Accounts Receivable: 65699000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 65699000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -71795000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -71795000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -116000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -116000.00
KLIN.SW income_statement (annual, 2026-03-31) — Amortization: 394000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 394000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 116000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 116000.00
KLIN.SW income_statement (annual, 2026-03-31) — Basic Average Shares: 8840000.00
KLIN.SW income_statement (annual, 2026-03-31) — Basic EPS: 0.66
KLIN.SW cash_flow (annual, 2026-03-31) — Beginning Cash Position: 16008000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Capital Expenditure: -8573000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Capital Stock: 28639000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Capital Stock: 28639000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 24848000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 24848000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 24848000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 24848000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -4731000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Change In Inventory: -5006000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -2377000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Change In Payable: 3650000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Change In Receivables: 3220000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Change In Working Capital: -1187000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Changes In Cash: 10005000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Common Stock: 28639000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Common Stock: 28639000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Common Stock Equity: 141556000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 141556000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Construction In Progress: 1433000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 1433000.00
KLIN.SW income_statement (annual, 2026-03-31) — Cost Of Revenue: 114609000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Current Assets: 210233000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Current Assets: 210233000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Current Liabilities: 127625000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 127625000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Current Provisions: 4572000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Current Provisions: 4572000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Defined Pension Benefit: 1600000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Defined Pension Benefit: 1600000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Depreciation: 5438000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 5832000.00
KLIN.SW income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 5832000.00
KLIN.SW income_statement (annual, 2026-03-31) — Depreciation Income Statement: 5438000.00
KLIN.SW income_statement (annual, 2026-03-31) — Diluted Average Shares: 8840000.00
KLIN.SW income_statement (annual, 2026-03-31) — Diluted EPS: 0.66
KLIN.SW income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 5793000.00
KLIN.SW income_statement (annual, 2026-03-31) — EBIT: 10450000.00
KLIN.SW income_statement (annual, 2026-03-31) — EBITDA: 16282000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: -1165000.00
KLIN.SW cash_flow (annual, 2026-03-31) — End Cash Position: 24848000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Financing Cash Flow: 7316000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Finished Goods: 9379000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Finished Goods: 9379000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Free Cash Flow: 1237000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -164000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 2319000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2319000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 65815000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 65815000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Gross PPE: 133741000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Gross PPE: 133741000.00
KLIN.SW income_statement (annual, 2026-03-31) — Gross Profit: 170781000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Hedging Assets Current: 167000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 167000.00
KLIN.SW income_statement (annual, 2026-03-31) — Interest Expense: 1690000.00
KLIN.SW income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 1690000.00
KLIN.SW income_statement (annual, 2026-03-31) — Interest Income: 205000.00
KLIN.SW income_statement (annual, 2026-03-31) — Interest Income Non Operating: 205000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Inventories Adjustments Allowances: -12171000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Inventories Adjustments Allowances: -12171000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Inventory: 108444000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Inventory: 108444000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Invested Capital: 141556000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Invested Capital: 141556000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Investing Cash Flow: -7121000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 116000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 116000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Investmentsin Joint Venturesat Cost: 2781000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Investmentsin Joint Venturesat Cost: 2781000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 2781000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 2781000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Long Term Provisions: 11298000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 11298000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 44009000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 44009000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: 0.00
KLIN.SW income_statement (annual, 2026-03-31) — Net Income: 5793000.00
KLIN.SW income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 5793000.00
KLIN.SW income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 5793000.00
KLIN.SW income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 5793000.00
KLIN.SW income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 5793000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 5793000.00
KLIN.SW income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 5793000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Net Intangibles Purchase And Sale: -1315000.00
KLIN.SW income_statement (annual, 2026-03-31) — Net Interest Income: -1485000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 423000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 12047000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -2734000.00
KLIN.SW income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -1485000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Net PPE: 61946000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Net PPE: 61946000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -6229000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 14781000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 139237000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 139237000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 11475000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 11475000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1231000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1231000.00
KLIN.SW income_statement (annual, 2026-03-31) — Normalized EBITDA: 16282000.00
KLIN.SW income_statement (annual, 2026-03-31) — Normalized Income: 5793000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Operating Cash Flow: 9810000.00
KLIN.SW income_statement (annual, 2026-03-31) — Operating Income: 9578000.00
KLIN.SW income_statement (annual, 2026-03-31) — Operating Revenue: 285390000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 8840000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 8840000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 2936000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 2936000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 2319000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 2319000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Other Inventories: 50750000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Other Inventories: 50750000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Other Non Cash Items: 220000.00
KLIN.SW income_statement (annual, 2026-03-31) — Other Operating Expenses: 30755000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Other Properties: 26663000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Other Properties: 26663000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Other Receivables: 7075000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Other Receivables: 7075000.00
KLIN.SW income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Payables: 26260000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Payables: 26260000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Prepaid Assets: 500000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 500000.00
KLIN.SW income_statement (annual, 2026-03-31) — Pretax Income: 8760000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Properties: 61636000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Properties: 61636000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Purchase Of Business: 0.00
KLIN.SW cash_flow (annual, 2026-03-31) — Purchase Of Intangibles: -1315000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Purchase Of Investment: -611000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Purchase Of PPE: -7258000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Raw Materials: 637000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Raw Materials: 637000.00
KLIN.SW income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 114609000.00
KLIN.SW income_statement (annual, 2026-03-31) — Reconciled Depreciation: 5832000.00
KLIN.SW income_statement (annual, 2026-03-31) — Rent And Landing Fees: 3500000.00
KLIN.SW income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 3500000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Retained Earnings: 76336000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 76336000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Sale Of Investment: 1034000.00
KLIN.SW cash_flow (annual, 2026-03-31) — Sale Of PPE: 1029000.00
KLIN.SW income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 8200000.00
KLIN.SW income_statement (annual, 2026-03-31) — Selling General And Administration: 8200000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Share Issued: 8840000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Share Issued: 8840000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Stockholders Equity: 141556000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 141556000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Tangible Book Value: 139237000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 139237000.00
KLIN.SW income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
KLIN.SW income_statement (annual, 2026-03-31) — Tax Provision: 2967000.00
KLIN.SW income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.34
KLIN.SW balance_sheet (annual, 2026-03-31) — Taxes Receivable: 3500000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 3500000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Total Assets: 290497000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Total Assets: 290497000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Total Capitalization: 141556000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 141556000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 141556000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 141556000.00
KLIN.SW income_statement (annual, 2026-03-31) — Total Expenses: 275812000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 148941000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 148941000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 80264000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 80264000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 21316000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 21316000.00
KLIN.SW income_statement (annual, 2026-03-31) — Total Operating Income As Reported: 10262000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Total Tax Payable: 4900000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 4900000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Work In Process: 59849000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Work In Process: 59849000.00
KLIN.SW balance_sheet (annual, 2026-03-31) — Working Capital: 82608000.00
KLIN.SW balance_sheet (quarterly, 2026-03-31) — Working Capital: 82608000.00
KLM.V balance_sheet (annual, 2021-10-31) — Duefrom Related Parties Current: 0.00
KLM.V balance_sheet (annual, 2021-10-31) — Dueto Related Parties Current: 29808.00
KLM.V cash_flow (annual, 2021-10-31) — Operating Gains Losses: -65399.00
KLM.V balance_sheet (annual, 2021-10-31) — Other Receivables: 8887.00
KLM.V income_statement (annual, 2021-10-31) — Other Special Charges: -65399.00
KLM.V cash_flow (annual, 2021-10-31) — Purchase Of PPE: -52060.00
KLM.V income_statement (annual, 2021-10-31) — Rent And Landing Fees: 7744.00
KLM.V income_statement (annual, 2021-10-31) — Rent Expense Supplemental: 7744.00
KLM.V income_statement (annual, 2022-10-31) — +Operating Expense: 301027.00
KLM.V income_statement (annual, 2022-10-31) — +Total Revenue: 0.00
KLM.V balance_sheet (annual, 2022-10-31) — Accounts Payable: 246982.00
KLM.V balance_sheet (annual, 2022-10-31) — Accounts Receivable: 3573.00
KLM.V balance_sheet (annual, 2022-10-31) — Additional Paid In Capital: 138776.00
KLM.V cash_flow (annual, 2022-10-31) — Asset Impairment Charge: 117026.00
KLM.V income_statement (annual, 2022-10-31) — Basic Average Shares: 10886118.00
KLM.V income_statement (annual, 2022-10-31) — Basic EPS: -0.05
KLM.V cash_flow (annual, 2022-10-31) — Beginning Cash Position: 93664.00
KLM.V cash_flow (annual, 2022-10-31) — Capital Expenditure: -75841.00
KLM.V balance_sheet (annual, 2022-10-31) — Capital Stock: 10100588.00
KLM.V balance_sheet (annual, 2022-10-31) — Cash And Cash Equivalents: 30041.00
KLM.V balance_sheet (annual, 2022-10-31) — Cash Cash Equivalents And Short Term Investments: 30041.00
KLM.V balance_sheet (annual, 2022-10-31) — Cash Financial: 30041.00
KLM.V cash_flow (annual, 2022-10-31) — Cash Flow From Continuing Financing Activities: 235260.00
KLM.V cash_flow (annual, 2022-10-31) — Cash Flow From Continuing Investing Activities: -75841.00
KLM.V cash_flow (annual, 2022-10-31) — Cash Flow From Continuing Operating Activities: -223042.00
KLM.V cash_flow (annual, 2022-10-31) — Change In Payables And Accrued Expense: -48392.00
KLM.V cash_flow (annual, 2022-10-31) — Change In Prepaid Assets: 48429.00
KLM.V cash_flow (annual, 2022-10-31) — Change In Receivables: 5314.00
KLM.V cash_flow (annual, 2022-10-31) — Change In Working Capital: 5351.00
KLM.V cash_flow (annual, 2022-10-31) — Changes In Cash: -63623.00
KLM.V balance_sheet (annual, 2022-10-31) — Common Stock: 10100588.00
KLM.V balance_sheet (annual, 2022-10-31) — Common Stock Equity: 350.00
KLM.V cash_flow (annual, 2022-10-31) — Common Stock Issuance: 235260.00
KLM.V balance_sheet (annual, 2022-10-31) — Current Assets: 59100.00
KLM.V balance_sheet (annual, 2022-10-31) — Current Liabilities: 276790.00
KLM.V income_statement (annual, 2022-10-31) — Diluted Average Shares: 10886118.00
KLM.V income_statement (annual, 2022-10-31) — Diluted EPS: -0.05
KLM.V income_statement (annual, 2022-10-31) — Diluted NI Availto Com Stockholders: -550220.00
KLM.V balance_sheet (annual, 2022-10-31) — Dueto Related Parties Current: 29808.00
KLM.V income_statement (annual, 2022-10-31) — EBIT: -301027.00
KLM.V income_statement (annual, 2022-10-31) — EBITDA: -301027.00
KLM.V cash_flow (annual, 2022-10-31) — End Cash Position: 30041.00
KLM.V cash_flow (annual, 2022-10-31) — Financing Cash Flow: 235260.00
KLM.V cash_flow (annual, 2022-10-31) — Free Cash Flow: -298883.00
KLM.V income_statement (annual, 2022-10-31) — General And Administrative Expense: 136684.00
KLM.V income_statement (annual, 2022-10-31) — Impairment Of Capital Assets: 117026.00
KLM.V balance_sheet (annual, 2022-10-31) — Invested Capital: 350.00
KLM.V cash_flow (annual, 2022-10-31) — Investing Cash Flow: -75841.00
KLM.V cash_flow (annual, 2022-10-31) — Issuance Of Capital Stock: 235260.00
KLM.V cash_flow (annual, 2022-10-31) — Net Common Stock Issuance: 235260.00
KLM.V income_statement (annual, 2022-10-31) — Net Income: -550220.00
KLM.V income_statement (annual, 2022-10-31) — Net Income Common Stockholders: -550220.00
KLM.V income_statement (annual, 2022-10-31) — Net Income Continuous Operations: -550220.00
KLM.V income_statement (annual, 2022-10-31) — Net Income From Continuing And Discontinued Operation: -550220.00
KLM.V income_statement (annual, 2022-10-31) — Net Income From Continuing Operation Net Minority Interest: -550220.00
KLM.V cash_flow (annual, 2022-10-31) — Net Income From Continuing Operations: -550220.00
KLM.V income_statement (annual, 2022-10-31) — Net Income Including Noncontrolling Interests: -550220.00
KLM.V balance_sheet (annual, 2022-10-31) — Net PPE: 218040.00
KLM.V cash_flow (annual, 2022-10-31) — Net PPE Purchase And Sale: -75841.00
KLM.V balance_sheet (annual, 2022-10-31) — Net Tangible Assets: 350.00
KLM.V income_statement (annual, 2022-10-31) — Normalized EBITDA: -51834.00
KLM.V income_statement (annual, 2022-10-31) — Normalized Income: -301027.00
KLM.V cash_flow (annual, 2022-10-31) — Operating Cash Flow: -223042.00
KLM.V cash_flow (annual, 2022-10-31) — Operating Gains Losses: 132167.00
KLM.V income_statement (annual, 2022-10-31) — Operating Income: -301027.00
KLM.V income_statement (annual, 2022-10-31) — Operating Revenue: 0.00
KLM.V balance_sheet (annual, 2022-10-31) — Ordinary Shares Number: 11963017.00
KLM.V income_statement (annual, 2022-10-31) — Other Gand A: 64050.00
KLM.V income_statement (annual, 2022-10-31) — Other Income Expense: -249193.00
KLM.V income_statement (annual, 2022-10-31) — Other Operating Expenses: 164343.00
KLM.V income_statement (annual, 2022-10-31) — Other Special Charges: 132167.00
KLM.V balance_sheet (annual, 2022-10-31) — Payables: 276790.00
KLM.V balance_sheet (annual, 2022-10-31) — Payables And Accrued Expenses: 276790.00
KLM.V balance_sheet (annual, 2022-10-31) — Prepaid Assets: 25486.00
KLM.V income_statement (annual, 2022-10-31) — Pretax Income: -550220.00
KLM.V cash_flow (annual, 2022-10-31) — Purchase Of PPE: -75841.00
KLM.V balance_sheet (annual, 2022-10-31) — Receivables: 3573.00
KLM.V income_statement (annual, 2022-10-31) — Rent And Landing Fees: 0.00
KLM.V income_statement (annual, 2022-10-31) — Rent Expense Supplemental: 0.00
KLM.V balance_sheet (annual, 2022-10-31) — Retained Earnings: -10239014.00
KLM.V income_statement (annual, 2022-10-31) — Salaries And Wages: 72634.00
KLM.V income_statement (annual, 2022-10-31) — Selling General And Administration: 136684.00
KLM.V balance_sheet (annual, 2022-10-31) — Share Issued: 11963017.00
KLM.V income_statement (annual, 2022-10-31) — Special Income Charges: -249193.00
KLM.V cash_flow (annual, 2022-10-31) — Stock Based Compensation: 72634.00
KLM.V balance_sheet (annual, 2022-10-31) — Stockholders Equity: 350.00
KLM.V balance_sheet (annual, 2022-10-31) — Tangible Book Value: 350.00
KLM.V income_statement (annual, 2022-10-31) — Tax Effect Of Unusual Items: 0.00
KLM.V income_statement (annual, 2022-10-31) — Tax Rate For Calcs: 0.00
KLM.V balance_sheet (annual, 2022-10-31) — Total Assets: 277140.00
KLM.V balance_sheet (annual, 2022-10-31) — Total Capitalization: 350.00
KLM.V balance_sheet (annual, 2022-10-31) — Total Equity Gross Minority Interest: 350.00
KLM.V income_statement (annual, 2022-10-31) — Total Expenses: 301027.00
KLM.V balance_sheet (annual, 2022-10-31) — Total Liabilities Net Minority Interest: 276790.00
KLM.V balance_sheet (annual, 2022-10-31) — Total Non Current Assets: 218040.00
KLM.V balance_sheet (annual, 2022-10-31) — Total Non Current Liabilities Net Minority Interest: 0.00
KLM.V income_statement (annual, 2022-10-31) — Total Unusual Items: -249193.00
KLM.V income_statement (annual, 2022-10-31) — Total Unusual Items Excluding Goodwill: -249193.00
KLM.V balance_sheet (annual, 2022-10-31) — Working Capital: -217690.00
KLM.V income_statement (annual, 2023-10-31) — +Operating Expense: 320029.00
KLM.V income_statement (annual, 2023-10-31) — +Total Revenue: 0.00
KLM.V balance_sheet (annual, 2023-10-31) — Accounts Payable: 253308.00
KLM.V balance_sheet (annual, 2023-10-31) — Accounts Receivable: 9314.00
KLM.V balance_sheet (annual, 2023-10-31) — Additional Paid In Capital: 219800.00
KLM.V cash_flow (annual, 2023-10-31) — Asset Impairment Charge: 274621.00
KLM.V income_statement (annual, 2023-10-31) — Basic Average Shares: 16975128.00
KLM.V income_statement (annual, 2023-10-31) — Basic EPS: -0.04
KLM.V cash_flow (annual, 2023-10-31) — Beginning Cash Position: 30041.00
KLM.V cash_flow (annual, 2023-10-31) — Capital Expenditure: -15030.00
KLM.V balance_sheet (annual, 2023-10-31) — Capital Stock: 11358713.00
KLM.V balance_sheet (annual, 2023-10-31) — Cash And Cash Equivalents: 3903.00
KLM.V balance_sheet (annual, 2023-10-31) — Cash Cash Equivalents And Short Term Investments: 3903.00
KLM.V balance_sheet (annual, 2023-10-31) — Cash Financial: 3903.00
KLM.V cash_flow (annual, 2023-10-31) — Cash Flow From Continuing Financing Activities: 74930.00
KLM.V cash_flow (annual, 2023-10-31) — Cash Flow From Continuing Investing Activities: -15030.00
KLM.V cash_flow (annual, 2023-10-31) — Cash Flow From Continuing Operating Activities: -86038.00
KLM.V cash_flow (annual, 2023-10-31) — Change In Payables And Accrued Expense: 52180.00
KLM.V cash_flow (annual, 2023-10-31) — Change In Prepaid Assets: 12984.00
KLM.V cash_flow (annual, 2023-10-31) — Change In Receivables: -5741.00
KLM.V cash_flow (annual, 2023-10-31) — Change In Working Capital: 59423.00